Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 30 Jun 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | HDFC Large and Mid Cap Fund |
|---|---|
| 30 Jun 2014 | ₹100.00 |
| 05 Jul 2015 | ₹112.05 |
| 08 Jul 2016 | ₹107.44 |
| 13 Jul 2017 | ₹131.06 |
| 17 Jul 2018 | ₹131.33 |
| 22 Jul 2019 | ₹136.34 |
| 25 Jul 2020 | ₹126.71 |
| 30 Jul 2021 | ₹210.62 |
| 03 Aug 2022 | ₹237.72 |
| 08 Aug 2023 | ₹296.75 |
| 11 Aug 2024 | ₹424.51 |
| 16 Aug 2025 | ₹427.80 |
| 20 Aug 2026 | ₹454.75 |
| Metric | HDFC · Direct NAV ₹373.46 Very High risk ★★☆☆☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +4.15% | +6.71% | |
| +15.58% | +16.28% | |
| +16.79% | +15.15% | |
| +15.00% | +15.07% | |
| +13.29% | +15.33% | |
| +14.76% | — | |
| +15.83% | +17.48% | |
| +15.68% | +16.77% | |
| +15.00% | +16.31% | |
| Risk | ||
| 14.94% | 14.81% | |
| 0.61 | 0.61 | |
| 0.82 | 0.82 | |
| -39.49% | -35.67% | |
| Nifty Midcap 150 | — | |
| -0.82% | +0.30% | |
| 0.88 | 0.83 | |
| 86.0% | 84.1% | |
| 84.7% | 78.7% | |
| 0.90% | 1.07% | |
| ₹28,339Cr | ₹3,576Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 7% | 42% | |
| Dhruv Muchhal | — | |
| 30 Jun 2014 | — | |
| 237 | — | |
| 20.2% | — | |
| 0.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.